The effect of prolonged therapy with MMX™ mesalamine in patients with acute, mild-to-moderate ulcerative colitis

被引：0
|
作者：
Lichtenstein, Gary R.
Kamm, Michael A.
Panaccione, Remo
Barrett, Karen
Lees, Kirstin
Joseph, Raymond E.
机构：
[1] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA
[2] St Marks Hosp, Dept Gastroenterol, London EC1V 2PS, England
[3] Univ Calgary, Div Gastroenterol, Calgary, AB T2N 1N4, Canada
[4] Shire Pharmaceut Inc, Basingstoke, Hants, England
[5] Shire Pharmaceut Inc, Wayne, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2007年 / 102卷
关键词：
D O I：
10.14309/00000434-200709002-00940
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
940
引用
收藏
页码：S463 / S463
页数：1
相关论文
共 50 条
  • [31] Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis
    Danese, S.
    Siegel, C. A.
    Peyrin-Biroulet, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1095 - 1103
  • [32] A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis
    Danese, Silvio
    Hart, Ailsa
    Dignass, Axel
    Fiorino, Gionata
    Louis, Edouard
    Bonovas, Stefanos
    D'Haens, Geert
    Dotan, Iris
    Rogler, Gerhard
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (09) : 1171 - 1182
  • [33] Patients With Mild-to-Moderate Ulcerative Colitis Experience Symptom Improvement 1 Week After Commencing Treatment With MMX® Mesalamine 2.4g/Day for Induction of Remission
    Kane, Sunanda V.
    Solomon, Dory M.
    Palmen, Mary
    Barrett, Karen
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S700 - S700
  • [34] Budesonide MMX and Mesalamine to Induce Remission in Patients With Ulcerative Colitis
    Criscuoli, Valeria
    Sinagra, Emanuele
    Cottone, Mario
    [J]. GASTROENTEROLOGY, 2013, 144 (03) : E23 - E23
  • [35] Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
    Hoy, Sheridan M.
    [J]. DRUGS, 2015, 75 (08) : 879 - 886
  • [36] Budesonide MMX®: A Review of Its Use in Patients with Mild to Moderate Ulcerative Colitis
    Sheridan M. Hoy
    [J]. Drugs, 2015, 75 : 879 - 886
  • [37] A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS
    Danese, Silvio
    Hart, Ailsa
    Dignass, Axel
    Fiorino, Gionata
    Louis, Edouard
    D'Haens, Geert R.
    Dotan, Iris
    Rogler, Gerhard
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1129 - S1129
  • [38] MMX mesalazine is well tolerated during 12 months' maintenance treatment of mild-to-moderate ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Barrett, K.
    Joseph, R. E.
    [J]. GUT, 2007, 56 : A113 - A113
  • [39] Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
    Bossa, Fabrizio
    Latiano, Anna
    Rossi, Luigia
    Magnani, Mauro
    Palmieri, Orazio
    Dallapiccola, Bruno
    Serafini, Sonja
    Damonte, Glanluca
    De Santo, Ermelinda
    Andriulli, Angelo
    Annese, Vito
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10): : 2509 - 2516
  • [40] The Efficacy and Safety of Mesalamine and Probiotics in Mild-to-Moderate Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Tian, Chunying
    Huang, Yang
    Wu, Xiaoxia
    Xu, Chuhan
    Bu, Huaien
    Wang, Hongwu
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
12345